Hypha Labs, Inc.
FUNI
$0.029
-$0.001-3.33%
OTC PK
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | -- | -- | -- | -- | -- |
Cost of Revenue | -- | -- | -- | -- | -- |
Gross Profit | -- | -- | -- | -- | -- |
SG&A Expenses | 1.31M | 502.80K | 613.60K | 574.00K | 70.60K |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 1.31M | 502.80K | 613.60K | 574.00K | 70.60K |
Operating Income | -1.31M | -502.80K | -613.60K | -574.00K | -70.60K |
Income Before Tax | -1.34M | -477.80K | -729.60K | -8.00K | -141.00K |
Income Tax Expenses | -- | -11.80K | -22.70K | 48.70K | -- |
Earnings from Continuing Operations | -1.34M | -466.00K | -706.90K | -56.70K | -141.00K |
Earnings from Discontinued Operations | -- | 0.00 | -- | 292.50K | 292.60K |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -1.34M | -466.00K | -706.90K | 235.80K | 151.60K |
EBIT | -1.31M | -502.80K | -613.60K | -574.00K | -70.60K |
EBITDA | -1.30M | -501.90K | -613.50K | -- | -- |
EPS Basic | -0.01 | 0.00 | -0.01 | 0.00 | 0.00 |
Normalized Basic EPS | -0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
EPS Diluted | -0.01 | 0.00 | -0.01 | 0.00 | 0.00 |
Normalized Diluted EPS | -0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Basic Shares Outstanding | 124.62M | 118.58M | 107.73M | 92.08M | 87.10M |
Average Diluted Shares Outstanding | 124.62M | 118.58M | 107.73M | 92.08M | 87.10M |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |